Report Highlights
The global market for healthcare interoperability solutions is expected to increase from $3.4 billion in 2023 to $6.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.7% during the forecast period of 2023-2028.
Report Includes
- 21 tables
- An overview of the global market for healthcare interoperability solutions
- Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
- Discussion of the current and future market potential and quantification of the market by type, deployment, solutions, level, end user, and region
- Information on the latest developments in the healthcare interoperability solutions and new industry research, upcoming technologies, government regulations and mandates, and economic trends
- Discussion of challenges related to commercialization and how to overcome them, and ESG trends of the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, partnerships and alliances, patents, and other market strategies
- Company profiles of major players within the industry, including Oracle Corp., Koninklijke Philips N.V., NextGen Healthcare Inc., Allscripts Healthcare Solutions LLC, and Infor Inc.
Report Scope
This report aims to provide a comprehensive study of the global healthcare interoperability solutions market. It provides a detailed description of the different types of healthcare interoperability solutions and their current and historical market revenues.
Healthcare interoperability solutions include services and software solutions. This report also includes a detailed study of deployments of healthcare interoperability solutions including cloud-based and on-premise. An in-depth analysis of the global healthcare interoperability solutions market includes historical data and market projection on sales by type, deployments, interoperability level, end-user, and region.
For an in-depth understanding of the market, profiles of market participants, key marketed solutions, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses factors driving and restraining the global healthcare interoperability solutions market.
Report Synopsis
| Report Metrics | Details | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||
| Forecast period considered | 2023-2028 | ||||||||||
| Base year market size | $2.8 billion | ||||||||||
| Market size forecast | $6.1 billion | ||||||||||
| Growth rate | CAGR of 12.7% for the forecast period of 2023-2028 | ||||||||||
| Units considered | $ Millions | ||||||||||
| Segments covered | Type, Deployment, Level of Interoperability, End User | ||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||
| Countries covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Russia, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, China, India, Japan, South Korea, Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia, Middle East and Africa, South America | ||||||||||
| Key Market Drivers |
|
||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
- Government regulations and mandates.
- Value-based care models.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Pharmacy Automation: Technologies and Global Markets
The global market for pharmacy automation is estimated to increase from $7.8 billion in 2023 to reach $12.7 billion by 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023 through 2028.
Medical Device Coatings: Global Markets
The global market for medical device coatings is estimated to increase from $5.8 billion in 2022 to reach $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 10.9% from 2022 through 2027.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Healthcare Cloud Computing: Global Markets to 2022
The global market for cloud technologies in healthcare was $16.1 billion in 2016. The market should reach $20.2 billion in 2017 and $35.0 billion by 2022, growing at a compound annual growth rate (CAGR) of 11.6% during 2017-2022.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More